AAPG

Ascentage Pharma Group International (AAPG)

About Ascentage Pharma Group International (AAPG)

Ascentage Pharma Group International Co., Ltd. is a clinical-stage biotechnology company. It engages in the development of novel therapies for cancers, hepatitis B virus, or HBV, and age-related diseases. The company was founded by Da Jun Yang, Wang Shao Meng and Ming Guo in May 2009 and is headquartered in Suzhou, China.

Details

Daily high
$32.96
Daily low
$32.58
Price at open
$32.58
52 Week High
$48.45
52 Week Low
$17.00
Market cap
3.1B
Dividend yield
0.00%
Volume
1,472
Avg. volume
4,541
P/E ratio
-16.34

Ascentage Pharma Group International News

Details

Daily high
$32.96
Daily low
$32.58
Price at open
$32.58
52 Week High
$48.45
52 Week Low
$17.00
Market cap
3.1B
Dividend yield
0.00%
Volume
1,472
Avg. volume
4,541
P/E ratio
-16.34